Human medicines European public assessment report (EPAR): Ranluspec, ranibizumab, Date of authorisation: 10/02/2026, Revision: 1, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 24 April 2026 - 14:05

Human medicines European public assessment report (EPAR): Ranluspec, ranibizumab, Date of authorisation: 10/02/2026, Revision: 1, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/ranluspec

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters